{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:06:28Z","timestamp":1791983188729,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Les Amis de L\u2019institut Bordet and la Fondation Contre le Cancer"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejca.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T09:56:21Z","timestamp":1440669381000},"page":"2517-2524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy"],"prefix":"10.1016","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct01554943","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Evandro","family":"de Azambuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieveke","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Vandenbossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aftimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Bejarano","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shih-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Delhaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Focan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cornez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Vindevoghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Beauduin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lemort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart-Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9472","key":"10.1016\/j.ejca.2015.08.011_b0005","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejca.2015.08.011_b0010","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2015.08.011_b0015","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.3816\/CBC.2003.s.012","article-title":"Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?","volume":"4","author":"Kaklamani","year":"2003","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.011_b0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.2001.19.1.37","article-title":"Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation","volume":"19","author":"Zambetti","year":"2001","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.ejca.2015.08.011_b0025","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","article-title":"Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study","volume":"23","author":"Doyle","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.08.011_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08880018.2013.851753","article-title":"Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?","volume":"31","author":"Basar","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2015.08.011_b0035","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.echo.2008.10.005","article-title":"Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer","volume":"21","author":"Jurcut","year":"2008","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.ejca.2015.08.011_b0040","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1634\/theoncologist.12-9-1124","article-title":"Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers","volume":"12","author":"Mercuro","year":"2007","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.ejca.2015.08.011_b0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup","year":"2004","journal-title":"Heart Br Card Soc"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.011_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/annonc\/mdj003","article-title":"Troponins in prediction of cardiotoxic effects","volume":"17","author":"Cardinale","year":"2006","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2015.08.011_b0055","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejca.2015.08.011_b0060","first-page":"3651","article-title":"Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors","volume":"25","author":"Perik","year":"2005","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.011_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/heart.88.1.81","article-title":"Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques","volume":"88","author":"Meinardi","year":"2002","journal-title":"Heart Br Card Soc"},{"issue":"12","key":"10.1016\/j.ejca.2015.08.011_b0070","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2001.19.12.3103","article-title":"Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer","volume":"19","author":"Piccart","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2015.08.011_b0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2008.17.2155","article-title":"Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study","volume":"27","author":"De Azambuja","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2015.08.011_b0080","first-page":"1086","article-title":"American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.011_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ejca.2015.08.011_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"issue":"17","key":"10.1016\/j.ejca.2015.08.011_b0095","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ejca.2015.08.011_b0100","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1158\/1078-0432.CCR-13-3490","article-title":"Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors","volume":"20","author":"Armenian","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2015.08.011_b0105","article-title":"Individual prediction of heart failure among childhood cancer survivors","author":"Chow","year":"2014","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.ejca.2015.08.011_b0110","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","article-title":"Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer","volume":"25","author":"Pinder","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.011_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/mdj034","article-title":"Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results","volume":"17","author":"Fumoleau","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.08.011_b0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12350-012-9512-2","article-title":"Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs","volume":"19","author":"Jiji","year":"2012","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.ejca.2015.08.011_b0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","article-title":"Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging\u2014a pilot study","volume":"141","author":"Wassmuth","year":"2001","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ejca.2015.08.011_b0130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejca.2015.08.011_b0135","first-page":"424","article-title":"Doxorubicin-induced cardiomyopathy 17 years after chemotherapy","volume":"39","author":"Kumar","year":"2012","journal-title":"Tex Heart Inst J Tex Heart Inst St Lukes Episcop Hosp Tex Child Hosp"},{"issue":"4","key":"10.1016\/j.ejca.2015.08.011_b0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000046508","article-title":"Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity","volume":"104","author":"Okumura","year":"2000","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1016\/j.ejca.2015.08.011_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2318-4-6","article-title":"The six-minute walk test in community dwelling elderly: influence of health status","volume":"23","author":"Bautmans","year":"2004","journal-title":"BMC Geriatr"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915008011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915008011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T20:57:11Z","timestamp":1537390631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915008011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":29,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0959804915008011"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.08.011","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}